Lymphology Association of North America (LANA) Practice Exam

Which of the following represents a contraindication for treating radiation-induced fibrosis?

1. When paresthesia and/or pain occur during or after treatment

2. All are true

3. When radiation-induced ulcers are present

4. When the skin cannot be moved over the underlying tissues/bones

The correct answer is: All are true

The correct answer signifies that all the provided scenarios are contraindications for treating radiation-induced fibrosis. Each of these circumstances presents specific risks that could complicate the treatment process or could lead to further complications for the patient. When paresthesia and/or pain manifest during or after treatment, this suggests that the patient may be experiencing nerve involvement or an inflammatory response that could be exacerbated by continuing treatment. It's critical to ensure that any therapy does not worsen these symptoms. The presence of radiation-induced ulcers indicates significant skin damage and vulnerability. Ulcers are areas where the skin has lost its integrity, and treating a region with such damage could lead to infection or further injury, which would complicate healing and potentially worsen the patient’s condition. Similarly, if the skin cannot be moved over the underlying tissues or bones, this points to severe fibrosis or tethering of the skin that can limit mobility. Treatment in such a case could cause additional harm, such as tearing or further damaging the fragile tissue, and may not yield any benefits. Recognizing all these factors is vital for patient safety and effective treatment planning. Together, they encompass the critical considerations that practitioners must evaluate before proceeding with treatment for cases involving radiation-induced fibrosis.